All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99


An Unusual Case of Ovarian Dysgerminoma Associated with Secondary Hemophagocytic Lymphohistiocytosis (HLH)

DOI: 10.4236/oalib.1109233, PP. 1-6

Subject Areas: Hematology, Gynecology & Obstetrics

Keywords: Pelvic Mass, Unexplained Fever, Pancytopenia, Hemophagocytic Lymphohistiocytosis, Ovarian Dysgerminoma

Full-Text   Cite this paper   Add to My Lib


Hemophagocytic Lymphohistiocytosis (HLH) is rare fulminant disease with high mortality. High clinical suspicion is required to diagnose HLH. Malignancy can cause secondary HLH. We reported a case of 45 years old lady with hypertension, presented with bilateral loin pain. On presentation to hospital, she was clinically ill, dehydrated and laboratory parameters showed severe acute kidney injury. CECT abdomen showed huge pelvic mass. Throughout ward admission, she had period of unexplained fever and pancytopenia hence diagnosis of HLH was considered. She fulfilled criteria of HLH and decision was made to remove the mass. Her blood counts recovered after ovarian tumour removed which subsequently HPE came back as ovarian dysgerminoma. However, she succumbed due to invasive fungal infection and upper gastro intestinal bleeding as a result of prolonged period of immunosuppression. HLH is uncommon and likely underdiagnosed disease. Diagnosis of HLH is often challenging as disease manifestation is non-specific, hence early recognition and intervention will improve patient outcome and survival.

Cite this paper

Ali, N. H. , Radhakrishnan, A. P. and Saaya, M. I. (2022). An Unusual Case of Ovarian Dysgerminoma Associated with Secondary Hemophagocytic Lymphohistiocytosis (HLH). Open Access Library Journal, 9, e9233. doi:


[1]  Kilic, C., Cakir, C., Yuksel, D., Kilic, F., Kayikcioglu, F., Koc, S., et al. (2021) Ovarian Dysgerminoma: A Tertiary Center Experience. Journal of Adolescent and Young Adult Oncology, 10, 303-308.
[2]  Sailer, S. (1940) Ovarian Dysgerminoma. The American Journal of Cancer, 38, 473-482.
[3]  Arndt, T., Taube, E.T., Deubzer, H.E., Rothe, K., et al. (2022) Management of Malignant Dysgerminoma of the Ovary. European Journal of Gynaecological Oncology, 43, 353-362.
[4]  George, M.R. (2014) Hemophagocytic Lymphohistiocytosis: Review of Etiologies and Management. Journal of Blood Medicine, 5, 69-86.
[5]  Filipovich, A.H. (2009) Hemophagocytic Lymphohistiocytosis (HLH) and Related Disorders. Hematology, ASH Education Program, 1, 127-131.
[6]  Farkas, J. (2016) PulmCrit-Sepsis 4.0: Understanding Sepsis-HLH Overlap Syndrome.
[7]  La Rosee, P., Horne, A.C., Hines, M., von Bahr Greenwood, T., Machowicz, R., Berliner, N., et al. (2019) Recommendations for the Management of Hemophagocytic Lymphohistiocytosis in Adults. Blood, 133, 2465-2477.
[8]  Wang, H.L., Xiong, L.X., Tang, W.P., Zhou, Y. and Li, F. (2017) A Systematic Review of Malignancy-Associated Hemophagocytic Lymphohistiocytosis That Needs More Attentions. Oncotarget, 8, 59977-59985.
[9]  Nosratian-Baskovic, M., Tan, B., Folkins, A., Chisholm, K.M. and Dorigo, O. (2016) Hemophagocytic Lymphohistiocytosis as a Paraneoplastic Syndrome Associated with Ovarian Dysgerminoma. Gynecology Oncology Report, 38-41.
[10]  von Lilienfeld-Toal, M., Wagener, J., Einsele, H., Cornely, O.A. and Kurzai, O. (2019) Invasive Fungal Infection. Deutsches Ärzteblatt International, 116, 271-278.


comments powered by Disqus

Contact Us